文献速递瓣膜病与结构性心脏病

主动脉瓣置换术后患者-人工瓣膜不匹配

Patient-prosthesis mismatch following aortic valve replacement.
PubMed 文献 · Heart · 2019-01-01

本文综述近10年关于主动脉瓣置换术后患者-人工瓣膜不匹配(PPM)的患病率、结局及防治选择。严重PPM定义为指数化有效瓣口面积(iEOA)<0.65 cm²/m²,患病率在8%至近80%之间。PPM可能与死亡率相关,尤其严重PPM,但后者仅占10-15%;中度PPM结局与无PPM无显著差异。PPM可能是合并症标志而非不良结局的危险因素,重点应放在预防。

要点

  • 严重PPM定义为iEOA<0.65 cm²/m²,患病率8%-近80%。
  • PPM与围术期卒中、肾衰竭及左室质量消退不足相关。
  • 唯一有效干预为再次手术植入更大瓣膜和/或瓣环扩大,重点在预防。

核心结论

  • PPM可能是合并症标志而非不良结局的危险因素。
  • 严重PPM仅占10-15%,中度PPM结局与无PPM无显著差异。
  • 重点应放在预防PPM。

研究设计与样本

  • 综述近10年关于主动脉瓣置换术后PPM的文献。

主要发现

  • PPM患病率在个体研究中为8%至近80%。
  • 严重PPM仅占10-15%,中度PPM结局与无PPM无显著差异。
  • PPM与围术期卒中、肾衰竭及左室质量消退不足相关。
  • 预测因素包括女性、高龄、高血压、糖尿病、肾衰竭及较高手术风险评分。

关键数值与推荐

  • 严重PPM定义为iEOA<0.65 cm²/m²。
  • AVR后持续心脏症状且人工瓣膜流速或压差高、计算有效瓣口面积小时应怀疑PPM。

临床怎么用

  • AVR后持续症状且高流速/压差、小有效瓣口面积时怀疑PPM。
  • 排除其他原因后,症状持续且药物治疗无效可考虑再干预。
  • 再干预决策需权衡缓解PPM的选项及预期获益与风险。
  • 唯一有效干预为再次手术植入更大瓣膜和/或瓣环扩大。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Patient-prosthesis mismatch (PPM) occurs when an implanted prosthetic valve is too small for the patient; severe PPM is defined as an indexed effective orifice area (iEOA) <0.65 cm2/m2 following aortic valve replacement (AVR). This review examines articles from the past 10 years addressing the prevalence, outcomes and options for prevention and treatment of PPM after AVR. Prevalence of PPM ranges from 8% to almost 80% in individual studies. PPM is thought to have an impact on mortality, mainly in patients with severe PPM, although severe PPM accounts for only 10-15% of cases. Outcomes of patients with moderate PPM are not significantly different to those without PPM. PPM is associated with higher rates of perioperative stroke and renal failure and lack of left ventricular mass regression. Predictors include female sex, older age, hypertension, diabetes, renal failure and higher surgical risk score. PPM may be a marker of comorbidity rather than a risk factor for adverse outcomes. PPM should be suspected in patients with persistent cardiac symptoms after AVR when there is high prosthetic valve velocity or gradient and a small calculated effective orifice area. After exclusion of other causes of increased transvalvular gradient, re-intervention may be considered if symptoms persist and are unresponsive to medical therapy. However, this decision needs to consider the available options to relieve PPM and whether expected benefits justify the risk of intervention. The only effective intervention is redo surgery with implantation of a larger valve and/or annular enlargement. Therefore, focus needs to be on prevention.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Bilkhu R, Jahangiri M, Otto CM, et al. Patient-prosthesis mismatch following aortic valve replacement. Heart. 2019. PMID: 30846522. doi:10.1136/heartjnl-2018-313515

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。